{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:13:15Z","timestamp":1788883995765,"version":"build-2803163510"},"reference-count":12,"publisher":"American Chemical Society (ACS)","issue":"5","license":[{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T00:00:00Z","timestamp":1583884800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,5,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Species of the blood fluke Schistosoma are responsible for schistosomiasis, the second most common parasitic disease, which is prevalent particularly in poor communities. Under redox pressure, schistosomes survive in mammalian hosts with the help of thioredoxin glutathione reductase, which is an essential selenoenzyme. A recent study identified compounds with extremely potent antischistosome activity. Most importantly, certain compounds were active against all major schistosomes across different life cycle stages, where even praziquantel, the drug of choice, fails. The data offer compounds that exceed WHO standards for leads for schistosomiasis therapy activity. The work may serve as the basis for the development of new antischistosome compounds.<\/jats:p>","DOI":"10.1021\/acsinfecdis.0c00072","type":"journal-article","created":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T10:36:27Z","timestamp":1583922987000},"page":"893-895","source":"Crossref","is-referenced-by-count":8,"title":["Potent Inhibitors of Thioredoxin Glutathione Reductase:\nGrail of Anti-Schistosome Drug within Reach?"],"prefix":"10.1021","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5559-289X","authenticated-orcid":true,"given":"Timir","family":"Tripathi","sequence":"first","affiliation":[{"name":"North-Eastern Hill University , , Umshing, , ,","place":["Shillong, Meghalaya, India, 793022"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purna B.","family":"Chetri","sequence":"additional","affiliation":[{"name":"North-Eastern Hill University , , Umshing, , ,","place":["Shillong, Meghalaya, India, 793022"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,3,11]]},"reference":[{"key":"2026081806112472500_cit1","unstructured":"World Health\nOrganization. Schistosomiasis, 2020. www.who.int\/schistosomiasis\/en\/ (accessed 2020-02-10)."},{"issue":"1","key":"2026081806112472500_cit2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","article-title":"Schistosomiasis","volume":"4","author":"McManus","year":"2018","journal-title":"Nat. Rev. Dis\nPrimers"},{"issue":"9936","key":"2026081806112472500_cit3","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/S0140-6736(13)61949-2","article-title":"Human schistosomiasis","volume":"383","author":"Colley","year":"2014","journal-title":"Lancet"},{"key":"2026081806112472500_cit4","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.actatropica.2017.08.002","article-title":"Schistosomiasis:\nDrugs used and treatment strategies","volume":"176","author":"Siqueira","year":"2017","journal-title":"Acta Trop."},{"issue":"2","key":"2026081806112472500_cit5","doi-asserted-by":"publisher","first-page":"e31456","DOI":"10.1371\/journal.pone.0031456","article-title":"Thioredoxin glutathione reductase\nas a novel drug target: evidence from Schistosoma japonicum","volume":"7","author":"Song","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"2026081806112472500_cit6","doi-asserted-by":"publisher","first-page":"e206","DOI":"10.1371\/journal.pmed.0040206","article-title":"Thioredoxin glutathione\nreductase\nfrom Schistosoma mansoni: an essential parasite enzyme and a key drug\ntarget","volume":"4","author":"Kuntz","year":"2007","journal-title":"PLoS Med."},{"issue":"12","key":"2026081806112472500_cit7","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.bbagen.2011.06.024","article-title":"Thioredoxin\nglutathione reductase:\nits role in redox biology and potential as a target for drugs against\nneglected diseases","volume":"1810","author":"Prast-Nielsen","year":"2011","journal-title":"Biochim. Biophys. Acta,\nGen. Subj."},{"issue":"4","key":"2026081806112472500_cit8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.parint.2016.05.013","article-title":"Unusual thiol-based\nredox metabolism\nof parasitic flukes","volume":"66","author":"Tripathi","year":"2017","journal-title":"Parasitol. Int."},{"key":"2026081806112472500_cit9","doi-asserted-by":"publisher","DOI":"10.1021\/acsinfecdis.9b00354","article-title":"Characterization of Lead Compounds\nTargeting the Selenoprotein Thioredoxin Glutathione Reductase for\nTreatment of Schistosomiasis","author":"Lyu","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"2026081806112472500_cit10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s40249-015-0071-z","article-title":"High-throughput\nscreening against thioredoxin glutathione reductase identifies novel\ninhibitors with potential therapeutic value for schistosomiasis","volume":"4","author":"Li","year":"2015","journal-title":"Infect Dis Poverty"},{"issue":"1","key":"2026081806112472500_cit11","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1371\/journal.pntd.0000127","article-title":"Quantitative\nhigh-throughput screen identifies inhibitors of the Schistosoma mansoni\nredox cascade","volume":"2","author":"Simeonov","year":"2008","journal-title":"PLoS Neglected Trop. Dis."},{"issue":"4","key":"2026081806112472500_cit12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nm1737","article-title":"Identification of\noxadiazoles as new drug leads for\nthe control of schistosomiasis","volume":"14","author":"Sayed","year":"2008","journal-title":"Nat. Med."}],"container-title":["ACS Infectious\nDiseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acsinfecdis.0c00072","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/6\/5\/893\/12721233\/id0c00072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article-pdf\/6\/5\/893\/12721233\/id0c00072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:11:29Z","timestamp":1787047889000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/aidcbc\/article\/6\/5\/893\/1292463\/Potent-Inhibitors-of-Thioredoxin-Glutathione"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,11]]},"references-count":12,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,3,11]]},"published-print":{"date-parts":[[2020,5,8]]}},"URL":"https:\/\/doi.org\/10.1021\/acsinfecdis.0c00072","relation":{},"ISSN":["2373-8227"],"issn-type":[{"value":"2373-8227","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,11]]}}}